Stockscreener 앱 받기
23.81
10.13%
2.19
시간 외 거래:
24.48
0.67
+2.81%
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 12.1%Here's Why - MarketBeat
Utah Medical Products Reports Q2 Decline - AOL.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Cut to $25.00 by Analysts at Piper Sandler - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q2 2025 Earnings Call Transcript - Insider Monkey
18,358 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Bought by XTX Topco Ltd - MarketBeat
Pfizer beats in Q2 earnings, reaffirms 2025 outlook [Video] - AOL.com
Interpace Biosciences Earnings Drop - AOL.com
Amphastar Pharmaceuticals Inc (AMPH) Q2 2025 Earnings Call Highlights: Strong Vaccine Sales and ... By GuruFocus - Investing.com Canada
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 500 Shares of Stock - MarketBeat
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now? - Yahoo Finance
Piper Sandler lowers Amphastar Pharmaceuticals stock price target on competitive headwinds - Investing.com Canada
Earnings call transcript: Amphastar Q2 2025 beats EPS forecast, stock rises - Investing.com Canada
Amphastar August 2025 presentation slides: long-term growth strategy faces near-term headwinds - Investing.com Canada
Amphastar Pharmaceuticals Topped Earnings And Is Doubling Down At Home - Finimize
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q2 Sales Targets, But Stock Soars 6% - TradingView
Atea (AVIR) Q2 Loss Narrows 8% - AOL.com
Amphastar advances U.S. manufacturing expansion and signals flat 2025 revenue outlook amid competitive pressures - MSN
Amphastar's Q2 2025: Unpacking Contradictions in BAQSIMI Growth, Manufacturing Capacity, and FDA Approvals - AInvest
Amphastar Pharmaceuticals, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals Reports Q2 2025 Earnings Highlights - TipRanks
Amphastar Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Amphastar (AMPH) Q2 2025 Earnings Call Transcript - AOL.com
Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Amphastar: Q2 Earnings Snapshot - San Francisco Chronicle
Amphastar Pharma Q2 revenue beats estimates - MarketScreener
Earnings Flash (AMPH) Amphastar Pharmaceuticals, Inc. Reports Q2 Revenue $174.4M, vs. FactSet Est of $174.0M - MarketScreener
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025 - ACCESS Newswire
Immunocore (IMCR) Q2 Revenue Jumps 30% - AOL.com
AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO [Video] - AOL.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 1-Year LowWhat's Next? - MarketBeat
Amphastar Pharmaceuticals (AMPH) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) to Release Quarterly Earnings on Thursday - MarketBeat
How many analysts rate Amphastar Pharmaceuticals Inc. as a “Buy”Explosive trading growth - Jammu Links News
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by GSA Capital Partners LLP - MarketBeat
How volatile is Amphastar Pharmaceuticals Inc. stock compared to the marketFree Trading Psychology Coaching - Jammu Links News
Is it the right time to buy Amphastar Pharmaceuticals Inc. stockBuild a portfolio that outperforms the market - Jammu Links News
How does Amphastar Pharmaceuticals Inc. compare to its industry peersAchieve breakthrough financial results today - Jammu Links News
What makes Amphastar Pharmaceuticals Inc. stock price move sharplyInvest smarter with advanced market data - Jammu Links News
What are the technical indicators suggesting about Amphastar Pharmaceuticals Inc.High-profit trading signals - Jammu Links News
What are Amphastar Pharmaceuticals Inc. company’s key revenue driversAchieve breakthrough performance in the market - Jammu Links News
Should I hold or sell Amphastar Pharmaceuticals Inc. stock in 2025Get daily updates on the hottest stocks - Jammu Links News
What catalysts could drive Amphastar Pharmaceuticals Inc. stock higher in 2025Achieve consistent double-digit growth - Jammu Links News
When is Amphastar Pharmaceuticals Inc. stock expected to show significant growthDouble-digit growth - Jammu Links News
Why is Amphastar Pharmaceuticals Inc. stock attracting strong analyst attentionMaster the art of timing market moves - Jammu Links News
Federated Hermes Inc. Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
How strong is Amphastar Pharmaceuticals Inc. company’s balance sheetPre Market Entry Points To Watch Now - Jammu Links News
Victory Capital Management Inc. Has $2.35 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
0.43%
0.47%
자본화:
|
볼륨(24시간):